Dr. Reddy's Laboratories
RDY
#1699
Rank
ยฃ8.90 B
Marketcap
ยฃ10.64
Share price
0.35%
Change (1 day)
-5.56%
Change (1 year)

Dr. Reddy's Laboratories (RDY) - Cash on Hand

Cash on Hand as of September 2025 : ยฃ0.58 Billion

According to Dr. Reddy's Laboratories's latest financial reports the company has ยฃ0.58 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Dr. Reddy's Laboratories - Cash on Hand chart (from 2001 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2025-03-31ยฃ0.52 B-32.19%
2024-03-31ยฃ0.77 B26.94%
2023-03-31ยฃ0.60 B37.04%
2022-03-31ยฃ0.44 B29.77%
2021-03-31ยฃ0.34 B24.4%
2020-03-31ยฃ0.27 B0.58%
2019-03-31ยฃ0.27 B19.35%
2018-03-31ยฃ0.22 B2.91%
2017-03-31ยฃ0.22 B-46.89%
2016-03-31ยฃ0.41 B-2.18%
2015-03-31ยฃ0.42 B27.95%
2014-03-31ยฃ0.33 B25.18%
2013-03-31ยฃ0.26 B20.05%
2012-03-31ยฃ0.22 B176.07%
2011-03-31ยฃ80.84 M-45.86%
2010-03-31ยฃ0.14 B78.16%
2009-03-31ยฃ83.81 M-44.58%
2008-03-31ยฃ0.15 B-28.97%
2007-03-31ยฃ0.21 B341.44%
2006-03-31ยฃ48.22 M-58.83%
2005-03-31ยฃ0.11 B36.16%
2004-03-31ยฃ86.03 M-11.07%
2003-03-31ยฃ96.74 M31.86%
2002-03-31ยฃ73.36 M914.62%
2001-03-31ยฃ7.23 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Pfizer
PFE
ยฃ11.23 B 1,806.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ1.65 B 180.35%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
ยฃ3.33 B 465.59%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novartis
NVS
ยฃ7.31 B 1,141.16%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
ยฃ7.83 B 1,230.10%๐Ÿ‡ซ๐Ÿ‡ท France